-Bringing Lourdes onboard is an important step in putting further emphasis on developing our QSP capacity. Her experience will be of essence in meeting the growing demand for QSP services from our clients, says Marylore Chenel, Chief Research Officer and the recruiting manager.
The recruitment of a senior scientist within QSP, like Lourdes Cucurull-Sanchez, will allow the company to split their previous merged areas of PBPK/PBBM and QSP, into two separate focus areas.
Physiologically based biopharmaceutics (PBBM) is one of the company’s strengths, and with emerging guidance from FDA and EMA recognizing the use of PBPK within biopharmaceutics, formulation and drug product development, it will play a larger role in supporting Pharmetheus clients. Marylore Chenel explains:
– We believe there are more possibilities for clients to make use of PBPK/PBBM, and we aim to contribute to developing new methodology, tools and best practices. With Erik Sjögren, leading the PBPK/PBBM, and Lourdes Cucurull-Sanchez heading the QSP, Pharmetheus is armed to address the needs within both areas.
Before joining Pharmetheus, Lourdes Cucurull-Sanchez has worked at large companies like Pfizer and GSK, in positions within clinical pharmacology, and she is looking forward to applying her skills at Pharmetheus.
– To me, Pharmetheus has always been synonymous with excellence, so I’m very proud of joining the team. I look forward to developing the QSP services together with the R&D team, and helping our clients accelerate and de-risk their drug development programmes, says Lourdes Cucurull-Sanchez.
With this addition, Pharmetheus R&D has a team of four scientific leads: Dr. Martin Bergstrand, Model Informed Drug Development (MIDD), Dr. Niclas Jonsson, Pharmacometrics, Ass. Prof. Erik Sjögren, PBPK/PBBM and Dr. Lourdes Cucurull-Sanchez, QSP, securing broad scientific expertise to develop its consultants within pharmacometrics and MIDD, and to offer support and advice to clients, whether it involves study design, strategy or modeling and simulation.
